221 related articles for article (PubMed ID: 22833083)
1. Pulmonary tumor thrombotic microangiopathy in patients with low-grade ovarian serous neoplasm: a clinicopathologic review of 2 cases of a previously unknown association.
Gru AA; Pai RK; Roma AA
Int J Gynecol Pathol; 2012 Sep; 31(5):438-42. PubMed ID: 22833083
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature.
Chinen K; Tokuda Y; Fujiwara M; Fujioka Y
Pathol Res Pract; 2010 Oct; 206(10):682-9. PubMed ID: 20554399
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor.
Chinen K; Fujino T; Horita A; Sakamoto A; Fujioka Y
Pathol Res Pract; 2009; 205(1):63-8. PubMed ID: 18835104
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary tumor thrombotic microangiopathy caused by metastatic ovarian high-grade serous carcinoma: a case report and literature review.
Fujita J; Hummel K; Xu Y
Cardiovasc Pathol; 2023; 65():107526. PubMed ID: 36781067
[TBL] [Abstract][Full Text] [Related]
5. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer.
Purga SL; Narula N; Horn EM; Karas MG
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26311016
[TBL] [Abstract][Full Text] [Related]
7. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
8. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
Hsu CY; Bristow R; Cha MS; Wang BG; Ho CL; Kurman RJ; Wang TL; Shih IeM
Clin Cancer Res; 2004 Oct; 10(19):6432-6. PubMed ID: 15475429
[TBL] [Abstract][Full Text] [Related]
9. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J
Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838
[TBL] [Abstract][Full Text] [Related]
10. A microscopic adenocarcinoma of the stomach with pulmonary tumor thrombotic microangiopathy in a 17-year-old male.
Hara A; Ichinoe M; Ogawa T; Shiraishi H; Okayasu I
Pathol Res Pract; 2005; 201(6):457-61. PubMed ID: 16136752
[TBL] [Abstract][Full Text] [Related]
11. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.
Takahashi F; Kumasaka T; Nagaoka T; Wakiya M; Fujii H; Shimizu K; Uchida K; Morio Y; Seyama K; Hino O; Takahashi K; Fukuchi Y
Pathol Int; 2009 Oct; 59(10):752-6. PubMed ID: 19788622
[TBL] [Abstract][Full Text] [Related]
13. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
14. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary tumor thrombotic microangiopathy.
Sato Y; Marutsuka K; Asada Y; Yamada M; Setoguchi T; Sumiyoshi A
Pathol Int; 1995 Jun; 45(6):436-40. PubMed ID: 7581935
[TBL] [Abstract][Full Text] [Related]
16. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
17. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factor.
Chinen K; Kazumoto T; Ohkura Y; Matsubara O; Tsuchiya E
Pathol Int; 2005 Jan; 55(1):27-31. PubMed ID: 15660700
[TBL] [Abstract][Full Text] [Related]
20. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
